MCK May 2024 510.000 put
| Previous close | 1.7500 |
| Open | 1.0700 |
| Bid | 0.1500 |
| Ask | 0.6500 |
| Strike | 510.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.3500 - 1.7600 |
| Contract range | N/A |
| Volume | |
| Open interest | 908 |
Insider MonkeyMcKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]
- GuruFocus.com
McKesson Corp (MCK) Q4 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic ...
Discover how McKesson's strategic initiatives and robust financial performance are shaping its industry leadership in Q4 2024.
- Reuters
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment. The segment also sells branded and generic drugs, as well as over-the-counter products and vaccines. Sales in the segment rose 11.5% in the fourth quarter to $68.79 billion, but missed analysts' estimate of $71.65 billion, according to LSEG data.
